The Glia Project is democratizing medical devices, starting by offering 3D-printed tourniquets and stethoscopes in war-torn areas like Gaza.

October 31, 2023 Check out STAT+

Sponsored By

Courtesy The Glia Project In Gaza, the Glia Project 3D prints tourniquets and stethoscopes The Glia Project is democratizing medical devices, starting by offering 3D-printed tourniquets and stethoscopes in war-torn areas like Gaza. By Lizzy Lawrence STAT+ | Tracking the FDA advisory panel on the first CRISPR-based treatment for sickle cell disease The FDA is seeking expert input about the methods used by Vertex and CRISPR Therapeutics to evaluate the risk of off-target editing. By Megan Molteni and Adam Feuerstein STAT+ | White House AI order calls for crackdown on abuses, harms in health care The actions taken in response to the executive order could dramatically reshape how AI is used in areas from drug research to hospital care. By Casey Ross Charles Krupa/AP Opinion: I lost my son to OxyContin. 'The Fall of the House of Usher' is my Sackler revenge fantasy I lost my son to Oxycontin. "The Fall of the House of Usher" is my (and many others') Sackler revenge fantasy. By Ed Bisch New CDC campaign asks health care leaders to take responsibility for reducing burnout The CDC and NIOSH campaign focuses on what health care leaders can do to make work environments less stressful. By Brittany Trang STAT+ | DeepMind touts AlphaFold's new skills as protein-folding AI models face off AlphaFold now has capabilities crucial to drug development: Computational biology advance based on predicting protein sequences. By Katie Palmer and Brittany Trang Adobe How skeptical should you be of an after-the-fact subgroup analysis in a failed clinical trial? After a failed clinical trial, companies often conduct further analyses to see if the compound might have been effective in smaller groups. By Erica Goode STAT+ | Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug Public Citizen argues that Amgen patent tactics will have added nearly $2 billion to Medicare spending for the drug by 2026. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser